Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hydroxychloroquine (plaquenil) (1 trial)
lisinopril (zestril) (1 trial)
tofacitinib (xeljanz) (1 trial)
autologous mesenchymal stem cells (2 trials)
Glomerulonephritis (Phase 2)
Kidney Failure, Chronic (Phase 1)
Lung Diseases, Interstitial (Phase 2)
Pneumonia (Phase 2)
Trials (4 total)
Trial APIs (4 total)